RESPONSE: Re: PET-CT Modification of RECIST Guidelines
نویسندگان
چکیده
منابع مشابه
RE: Imaging Features of Hepato-Splenic Amyloidosis at PET/CT
Regarding the imaging of hepatic amyloidosis with PET/CT, we read with interest the case report by Son and colleagues (1) in the Sep-Oct 2011 issue of the Korean Journal of Radiology. A few points need to be discussed with more detail. First, although the enhanced CT scan of the spleen exhibited a decreased and diffuse parenchymal attenuation, this observation was not sufficiently emphasized wi...
متن کاملImaging tumour response: beyond RECIST
One of the most widely employed quantitative measurements for assessing tumour response to treatment is the tumour diameter (RECIST criteria), usually determined on cross-sectional CT or MRI. This simple measurement is relatively reproducible and reduction in the maximum tumour diameter by 30% or more following therapy is taken as a sign of effective treatment. However, new targeted therapies m...
متن کاملGuidelines for the use of PET-CT in children.
Division of Imaging, Kings College, PET Centre at St Thomas’ Hospital, Guys’ and St Thomas’ Foundation NHS Trust, London, Great Ormond Street Hospital for Sick Children, City and Royal Victoria Hospitals Belfast, Leeds Teaching Hospitals NHS Trust, Blackpool Victoria Hospital, University College London Hospitals NHS Trust and Aberdeen Royal Infirmary, UK Correspondence to Dr Sally F. Barrington...
متن کاملFDG-PET/CT based response-adapted treatment
It has been shown that [(18)F]fluorodeoxyglucose (FDG)-positron emission tomography (PET) provides robust and reproducible data for early metabolic response assessment in various malignancies. This led to the initiation of several prospective multicenter trials in malignant lymphoma and adenocarcinoma of the esophagogastric junction, in order to investigate whether the use of PET-guided treatme...
متن کاملAn overview of clinical PET/CT
This article is intended to provide an overview of various aspects of clinical PET/CT. These include discussions of: (i) Important areas of clinical application; (ii) Opportunities in clinical research; (iii) Scanner and operating-mode considerations (e.g. BGO vs. LSO, LYSO or GSO scanners, 2D vs. 3D imaging). (iv) Study-specific considerations (e.g. patient preparation and positioning is...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 2004
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/djh150